Skip to main content

Day: August 1, 2025

Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic enterprise expanding into artificial intelligence through Tevogen.AI. Our mission remains steadfast: delivering clinically impactful, economically accessible therapies by leveraging cutting-edge science and technology. Tevogen has become a recognized name for its business philosophy of social responsibility, patient affordability and cost efficiency. In under five years, we validated our proprietary ExacTcell™ platform, completed successful proof-of-concept clinical trial of the platforms first product, established drug discovery R&D center — currently in the process...

Continue reading

Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion

Funds will support advancement of Tevogen.AI, the Company’s artificial intelligence–driven drug discovery initiative. The $1 million is part of up to $10 million in previously announced non‑dilutive grant funding from KRHP LLC.WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or the “Company) (Nasdaq: TVGN), today announced that it expects to receive $1 million in grant funding to advance Tevogen.AI, its artificial intelligence–powered drug discovery and development program. The funding would be provided under the previously announced grant agreement with KRHP LLC, under which Tevogen received $2 million in January 2025 and may receive up to an additional $8 million, for an aggregate of $10 million in non-dilutive funding. KRHP LLC is affiliated with an existing Tevogen investor. The Company...

Continue reading

Mandalay Obtains Final Order Approving Arrangement with Alkane

TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (“Mandalay” or the “Company”) (TSX: MND, OTCQB: MNDJF) is pleased to announce that the Supreme Court of British Columbia has issued a final order approving the previously announced plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”), pursuant to which Alkane Resources Limited (“Alkane”) will acquire all of the issued and outstanding common shares of Mandalay (“Mandalay Shares”). Under the Arrangement, shareholders of Mandalay will be entitled to receive, for each Mandalay Share held, 7.875 fully paid ordinary shares in the capital of Alkane. The receipt of the Final Order was the final substantive condition to closing the Arrangement. The Arrangement is expected to close on August 5, 2025. For Further Information Mandalay...

Continue reading

PCS Edventures! Provides Share Buyback Update

MERIDIAN, Idaho, Aug. 01, 2025 (GLOBE NEWSWIRE) — PCS Edventures!, Inc. (“PCSV”), a leading provider of TK-12 Science, Technology, Engineering and Mathematics (“STEM”) education programs, today announced that it has repurchased 3,736,170 of its outstanding shares on the open market in the period from July 07, 2025, up to and including July 28, 2025. The shares were repurchased at an average price of $0.0991 for a total consideration of $370,430.26. These repurchases were made as part of the 10 million share buyback program announced on April 10, 2025. The total number of shares repurchased under this program to date is 4,132,979 shares, for a total consideration of $425,234.71, which includes one private transaction for 284,959 shares at $0.14 and one private transaction for 11,850 shares at $0.11. PCS Edventures!, Inc. intends...

Continue reading

DeFi Development Corp. to Host X Spaces Event: “July 2025 Business Recap & AMA”

BOCA RATON, FL, Aug. 01, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) today announced it will host a live X Spaces conversation on Monday, August 4, 2025, at 1:30 p.m. Eastern Time, titled “July 2025 Business Recap & AMA.” The event will offer participants a detailed review of the Company’s recent business developments, key milestones, and strategic initiatives undertaken in July 2025. Additionally, the Company’s leadership team will host an interactive Ask-Me-Anything (AMA) session, providing investors and community members an opportunity to have their questions addressed. Participants can join the live event by visiting DeFi Development Corp.’s official X (formerly Twitter) account at the scheduled time. A recording of the conversation will be made available shortly after the event concludes. Join...

Continue reading

Barrick’s Sustainability Update Showcases Six Years of Transformational Impact

All amounts expressed in U.S. dollars TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) — Barrick Mining Corporation (NYSE:B)(TSX:ABX) today held its Annual Sustainability Update, an important forum for direct engagement with stakeholders focused on sustainability performance and priorities. The webinar follows the recent publication of the company’s comprehensive 2024 Sustainability Report and highlights key achievements across Barrick’s global operations. The company continues to advance foundational growth projects designed to create long-term value for all stakeholders through genuine partnerships. Barrick’s sustainability priorities include comprehensive reporting against the UN Sustainable Development Goals (SDGs), maintaining its unwavering commitment to workplace safety, and proactive forecasting and management of greenhouse gas...

Continue reading

Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)

Susvimo is the only continuous delivery treatment to provide reliable, long-term vision outcomes in nAMD, the leading cause of vision loss in people over the age of 60 With two refills per year, Susvimo maintained vision and stabilised the retina for five years, with durability maintained in approximately 95% of patients Susvimo was well tolerated over five years and has a well-characterised safety profileBasel, 01 August 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.1 Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving...

Continue reading

Atos Group – Availability of the 2025 Half-year Financial Report

Availability of the 2025 Half-year Financial Report  Paris, August 1, 2025 – Atos Group announces that its 2025 half-year financial report was published today on its website and filed with the French Financial Markets Authority (“AMF”). This document includes the 2025 half-year activity report, the financial statements for the first of 2025, the statutory auditors’ review report and the statement of the responsible person for the half-year financial report. It is available, in English and in French, on the Company’s website (www.atos.net). About Atos Group  Atos Group is a global leader in digital transformation with c. 70,000 employees and annual revenue of c. € 10 billion, operating in 67 countries under two brands — Atos for services and Eviden for products. European number one in cybersecurity, cloud and high-performance computing,...

Continue reading

ArcelorMittal publishes its 2025 half-year report

1 August 2025, 19.30 CET ArcelorMittal (the ‘Company’) has today published its half-year report for the six-month period ended 30 June 2025. The report is available on http://corporate.arcelormittal.com/ under Investors > Financial reports > Half-year reports, and on the electronic database of the Luxembourg Stock Exchange (www.bourse.lu/). The report has also been filed on Form 6-K with the U.S. Securities and Exchange Commission (SEC) and is available on http://corporate.arcelormittal.com/ under Investors > Financial reports > SEC filings.   ENDS About ArcelorMittal ArcelorMittal is one of the world’s leading integrated steel and mining companies with a presence in 60 countries and primary steelmaking operations in 15 countries. It is the largest steel producer in Europe, among the largest in the Americas, and has a growing presence...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.